TPTE2
gene geneOn this page
Also known as TPIP
Summary
TPTE2 (transmembrane phosphoinositide 3-phosphatase and tensin homolog 2, HGNC:17299) is a protein-coding gene on chromosome 13q12.11, encoding Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase TPTE2 (Q6XPS3). Acts as a lipid phosphatase, removing the phosphate in the D3 position of the inositol ring from phosphatidylinositol 3,4,5-trisphosphate.
TPIP is a member of a large class of membrane-associated phosphatases with substrate specificity for the 3-position phosphate of inositol phospholipids.
Source: NCBI Gene 93492 — RefSeq curated summary.
At a glance
- GWAS associations: 1
- Clinical variants (ClinVar): 104 total
- MANE Select transcript:
NM_001395978
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:17299 |
| Approved symbol | TPTE2 |
| Name | transmembrane phosphoinositide 3-phosphatase and tensin homolog 2 |
| Location | 13q12.11 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | TPIP |
| Ensembl gene | ENSG00000132958 |
| Ensembl biotype | protein_coding |
| OMIM | 606791 |
| Entrez | 93492 |
Gene structure
Transcript identifiers
Ensembl transcripts: 11 — 9 protein_coding, 2 nonsense_mediated_decay
ENST00000382978, ENST00000390680, ENST00000400103, ENST00000462409, ENST00000696857, ENST00000696858, ENST00000696859, ENST00000696860, ENST00000696861, ENST00000696988, ENST00000697147
RefSeq mRNA: 4 — MANE Select: NM_001395978
NM_001141968, NM_001395978, NM_130785, NM_199254
CCDS: CCDS45013, CCDS45014, CCDS9285
Canonical transcript exons
ENST00000697147 — 23 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001494134 | 19422877 | 19423164 |
| ENSE00001679534 | 19426425 | 19426517 |
| ENSE00001689428 | 19475573 | 19475623 |
| ENSE00001710546 | 19450263 | 19450344 |
| ENSE00001789231 | 19450076 | 19450164 |
| ENSE00003968651 | 19493448 | 19493501 |
| ENSE00003968653 | 19482488 | 19482547 |
| ENSE00003968655 | 19552571 | 19552673 |
| ENSE00003968656 | 19503224 | 19503277 |
| ENSE00003968661 | 19559028 | 19559129 |
| ENSE00003968662 | 19430468 | 19430547 |
| ENSE00003968663 | 19473914 | 19474075 |
| ENSE00003968664 | 19467225 | 19467344 |
| ENSE00003968668 | 19424947 | 19425017 |
| ENSE00003968670 | 19492850 | 19492903 |
| ENSE00003968672 | 19432473 | 19432578 |
| ENSE00003968674 | 19436226 | 19436306 |
| ENSE00003968675 | 19465255 | 19465318 |
| ENSE00003968676 | 19451165 | 19451225 |
| ENSE00003968677 | 19464456 | 19464520 |
| ENSE00003968678 | 19561434 | 19561532 |
| ENSE00003968679 | 19438092 | 19438153 |
| ENSE00003968680 | 19465465 | 19465564 |
Expression profiles
Bgee: expression breadth ubiquitous, 123 present calls, max score 83.17.
Top tissues by expression
129 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 83.17 | gold quality |
| right testis | UBERON:0004534 | 79.62 | gold quality |
| left testis | UBERON:0004533 | 79.05 | gold quality |
| testis | UBERON:0000473 | 78.84 | gold quality |
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 76.80 | gold quality |
| sural nerve | UBERON:0015488 | 62.98 | silver quality |
| prefrontal cortex | UBERON:0000451 | 59.91 | gold quality |
| bone marrow cell | CL:0002092 | 59.70 | silver quality |
| frontal cortex | UBERON:0001870 | 57.80 | gold quality |
| Brodmann (1909) area 9 | UBERON:0013540 | 57.67 | gold quality |
| dorsolateral prefrontal cortex | UBERON:0009834 | 57.42 | gold quality |
| cerebellar hemisphere | UBERON:0002245 | 57.23 | gold quality |
| cerebellar cortex | UBERON:0002129 | 57.21 | gold quality |
| cerebellum | UBERON:0002037 | 56.96 | gold quality |
| superior frontal gyrus | UBERON:0002661 | 56.63 | gold quality |
| mucosa of stomach | UBERON:0001199 | 56.34 | gold quality |
| putamen | UBERON:0001874 | 56.18 | gold quality |
| ventricular zone | UBERON:0003053 | 56.17 | gold quality |
| cerebral cortex | UBERON:0000956 | 56.14 | gold quality |
| anterior cingulate cortex | UBERON:0009835 | 55.96 | gold quality |
| right hemisphere of cerebellum | UBERON:0014890 | 55.75 | gold quality |
| right frontal lobe | UBERON:0002810 | 55.27 | gold quality |
| duodenum | UBERON:0002114 | 54.79 | gold quality |
| lymph node | UBERON:0000029 | 53.94 | gold quality |
| brain | UBERON:0000955 | 53.52 | gold quality |
| primary visual cortex | UBERON:0002436 | 53.38 | gold quality |
| mucosa of transverse colon | UBERON:0004991 | 52.85 | gold quality |
| hypothalamus | UBERON:0001898 | 52.78 | gold quality |
| caudate nucleus | UBERON:0001873 | 52.74 | gold quality |
| right adrenal gland cortex | UBERON:0035827 | 52.46 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 1.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | yes | 5.65 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
20 targeting TPTE2, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-5011-5P | 100.00 | 83.46 | 5820 |
| HSA-MIR-190A-3P | 100.00 | 80.35 | 5520 |
| HSA-MIR-3185 | 99.99 | 68.12 | 1959 |
| HSA-MIR-1197 | 99.70 | 67.75 | 1027 |
| HSA-MIR-7-5P | 99.67 | 70.53 | 1809 |
| HSA-MIR-1207-5P | 99.49 | 69.11 | 2983 |
| HSA-MIR-6722-3P | 99.45 | 67.62 | 1919 |
| HSA-MIR-410-3P | 99.27 | 69.98 | 2457 |
| HSA-MIR-10522-5P | 99.26 | 68.50 | 2087 |
| HSA-MIR-3978 | 99.24 | 68.39 | 2201 |
| HSA-MIR-4763-3P | 99.10 | 67.83 | 2649 |
| HSA-MIR-1909-3P | 99.03 | 66.56 | 1662 |
| HSA-MIR-4711-5P | 98.89 | 68.00 | 965 |
| HSA-MIR-3179 | 98.22 | 65.90 | 1445 |
| HSA-MIR-939-5P | 97.10 | 65.80 | 1579 |
| HSA-MIR-1343-5P | 96.48 | 66.06 | 1506 |
| HSA-MIR-6726-5P | 95.97 | 63.72 | 841 |
| HSA-MIR-4300 | 95.85 | 64.56 | 1003 |
| HSA-MIR-5591-5P | 95.85 | 64.76 | 1002 |
| HSA-MIR-127-3P | 93.92 | 66.42 | 36 |
Literature-anchored findings (GeneRIF, showing 4)
- the TPIP splice-variant (TPIP-C2) mRNA is expressed in human and mouse tissues and strongly inhibits cell growth in HeLa cells (PMID:22164291)
- findings suggest that C2-domain of TPIP-C2 may act as a dominant negative effector, which may bind to and arrest the cell proliferation signalling complex (PMID:22311048)
- TPTE2 was originally reported to be a phosphoinositide 3’-phosphatase, like the tumor suppressor PTEN. Later on, other homologous phosphatases, such as Ci-VSP and Dr-VSP, have been described. These proteins are 5’-phosphatases. More recently, using a chimeric construct, we have shown that the catalytic domain of TPTE2 behaves as a 5’-phosphatase as well. (PMID:22896666)
- The role of TPTE2 in gallbladder cancer cells (PMID:25676706)
Cross-species orthologs
3 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | tpte | ENSDARG00000056985 |
| mus_musculus | Tpte | ENSMUSG00000031481 |
| rattus_norvegicus | Tpte2 | ENSRNOG00000024837 |
Paralogs (6): TNS1 (ENSG00000079308), HVCN1 (ENSG00000122986), TNS3 (ENSG00000136205), TMEM266 (ENSG00000169758), PTEN (ENSG00000171862), TPTE (ENSG00000274391)
Protein
Protein identifiers
Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase TPTE2 — Q6XPS3 (reviewed: Q6XPS3)
Alternative names: Lipid phosphatase TPIP, TPTE and PTEN homologous inositol lipid phosphatase
All UniProt accessions (6): A0A8Q3SIW4, Q6XPS3, A0A8Q3SJ09, A0A8Q3SJ26, A0A8Q3SJ67, G3V171
UniProt curated annotations — full annotation on UniProt →
Function. Acts as a lipid phosphatase, removing the phosphate in the D3 position of the inositol ring from phosphatidylinositol 3,4,5-trisphosphate. Shows no phosphoinositide phosphatase activity.
Subcellular location. Endoplasmic reticulum membrane Endoplasmic reticulum membrane. Golgi apparatus membrane Cytoplasm.
Tissue specificity. Isoform 3 is expressed in testis, brain and stomach while isoform 4 seems to be testis-specific.
Miscellaneous. Expressed in testis, strongly inhibits cell growth in HeLa cells.
Isoforms (7)
| UniProt ID | Names | Canonical? |
|---|---|---|
| Q6XPS3-1 | 1, TPIP gamma | yes |
| Q6XPS3-2 | 2 | |
| Q6XPS3-3 | 3, TPIP alpha | |
| Q6XPS3-4 | 4, TPIP beta | |
| Q6XPS3-5 | 5 | |
| Q6XPS3-6 | 6, TPIP-C2 | |
| Q6XPS3-7 | 7 |
RefSeq proteins (4): NP_001135440, NP_001382907, NP_570141, NP_954863 (=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR000387 | Tyr_Pase_dom | Domain |
| IPR005821 | Ion_trans_dom | Domain |
| IPR014020 | Tensin_C2-dom | Domain |
| IPR016130 | Tyr_Pase_AS | Active_site |
| IPR027359 | Volt_channel_dom_sf | Homologous_superfamily |
| IPR029021 | Prot-tyrosine_phosphatase-like | Homologous_superfamily |
| IPR029023 | Tensin_phosphatase | Domain |
| IPR035892 | C2_domain_sf | Homologous_superfamily |
| IPR045102 | PTP_VSP_TPTE | Domain |
| IPR051281 | Dual-spec_lipid-protein_phosph | Family |
| IPR057023 | PTP-SAK | Domain |
Pfam: PF00520, PF10409, PF22784
Catalyzed reactions (Rhea), 1 shown:
- a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol-3,4,5-trisphosphate) + H2O = a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol-4,5-bisphosphate) + phosphate (RHEA:25017)
UniProt features (21 total): splice variant 7, transmembrane region 3, sequence variant 2, domain 2, compositionally biased region 2, chain 1, mutagenesis site 1, sequence conflict 1, region of interest 1, active site 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q6XPS3-F1 | 85.00 | 0.58 |
Functional residue map
Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.
Catalytic / active sites (1): 320 (phosphocysteine intermediate)
Mutagenesis-validated functional residues (1):
| Position | Phenotype |
|---|---|
| 320 | loss of activity. |
Function
Pathways and Gene Ontology
Reactome pathways
1 pathways
| ID | Pathway |
|---|---|
| R-HSA-1660514 | Synthesis of PIPs at the Golgi membrane |
MSigDB gene sets: 48 (showing top):
GOBP_PHOSPHOLIPID_METABOLIC_PROCESS, GOBP_PHOSPHATIDYLINOSITOL_METABOLIC_PROCESS, MODULE_493, GOBP_ORGANOPHOSPHATE_METABOLIC_PROCESS, GOBP_ORGANOPHOSPHATE_BIOSYNTHETIC_PROCESS, GOBP_PHOSPHOLIPID_BIOSYNTHETIC_PROCESS, GOBP_GLYCEROLIPID_METABOLIC_PROCESS, MODULE_285, MODULE_171, GOBP_GLYCEROLIPID_BIOSYNTHETIC_PROCESS, GOBP_GLYCEROPHOSPHOLIPID_METABOLIC_PROCESS, GOBP_LIPID_METABOLIC_PROCESS, GOBP_LIPID_BIOSYNTHETIC_PROCESS, GOBP_TRANSMEMBRANE_TRANSPORT, ACEVEDO_LIVER_CANCER_WITH_H3K27ME3_DN
GO Biological Process (8): phosphatidylinositol biosynthetic process (GO:0006661), lipid metabolic process (GO:0006629), phosphate-containing compound metabolic process (GO:0006796), monoatomic ion transport (GO:0006811), dephosphorylation (GO:0016311), monoatomic ion transmembrane transport (GO:0034220), transmembrane transport (GO:0055085), proton transmembrane transport (GO:1902600)
GO Molecular Function (6): monoatomic ion channel activity (GO:0005216), phosphatidylinositol-3,4,5-trisphosphate 3-phosphatase activity (GO:0016314), phosphatidylinositol-3,4-bisphosphate 3-phosphatase activity (GO:0051800), hydrolase activity (GO:0016787), phosphatase activity (GO:0016791), voltage-gated proton channel activity (GO:0030171)
GO Cellular Component (9): Golgi membrane (GO:0000139), cytoplasm (GO:0005737), endoplasmic reticulum membrane (GO:0005789), cytosol (GO:0005829), endoplasmic reticulum (GO:0005783), Golgi apparatus (GO:0005794), plasma membrane (GO:0005886), membrane (GO:0016020), monoatomic ion channel complex (GO:0034702)
Reactome top-level categories
Rollup of top-1 pathways:
| Category | Pathways |
|---|---|
| PI Metabolism | 1 |
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| cellular anatomical structure | 3 |
| cytoplasm | 3 |
| transport | 2 |
| endomembrane system | 2 |
| intracellular membrane-bounded organelle | 2 |
| biosynthetic process | 1 |
| phosphatidylinositol metabolic process | 1 |
| primary metabolic process | 1 |
| metabolic process | 1 |
| phosphate-containing compound metabolic process | 1 |
| monoatomic ion transport | 1 |
| transmembrane transport | 1 |
| cellular process | 1 |
| monoatomic cation transmembrane transport | 1 |
| monoatomic ion transmembrane transporter activity | 1 |
| channel activity | 1 |
| phosphatidylinositol trisphosphate phosphatase activity | 1 |
| phosphatidylinositol-3,4-bisphosphate phosphatase activity | 1 |
| catalytic activity | 1 |
| phosphoric ester hydrolase activity | 1 |
| proton channel activity | 1 |
| voltage-gated monoatomic cation channel activity | 1 |
| Golgi apparatus | 1 |
| bounding membrane of organelle | 1 |
| intracellular anatomical structure | 1 |
| organelle membrane | 1 |
| nuclear outer membrane-endoplasmic reticulum membrane network | 1 |
| endoplasmic reticulum subcompartment | 1 |
| membrane | 1 |
| cell periphery | 1 |
| transmembrane transporter complex | 1 |
Protein interactions and networks
STRING
1635 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| TPTE2 | MTMR2 | Q13614 | 861 |
| TPTE2 | TMEM266 | Q2M3C6 | 489 |
| TPTE2 | HAUS6 | Q7Z4H7 | 470 |
| TPTE2 | GUCY1A2 | P33402 | 469 |
| TPTE2 | PTEN | P60484 | 441 |
| TPTE2 | NUDT21 | O43809 | 433 |
| TPTE2 | NDUFS6 | O75380 | 432 |
| TPTE2 | PGAM2 | P15259 | 417 |
| TPTE2 | MTMR7 | Q9Y216 | 410 |
| TPTE2 | MTMR6 | Q9Y217 | 404 |
| TPTE2 | SDHA | P31040 | 389 |
| TPTE2 | OR10S1 | Q8NGN2 | 368 |
| TPTE2 | MTMR14 | Q8NCE2 | 348 |
| TPTE2 | ZNF530 | Q6P9A1 | 348 |
| TPTE2 | INPP5B | P32019 | 342 |
IntAct
10 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| TPTE2 | TLN1 | psi-mi:“MI:0407”(direct interaction) | 0.440 |
| TPTE2 | CALD1 | psi-mi:“MI:0915”(physical association) | 0.400 |
| TPTE2 | LMTK2 | psi-mi:“MI:0915”(physical association) | 0.370 |
| TPTE2 | AATK | psi-mi:“MI:0915”(physical association) | 0.370 |
| TPTE2 | PTK7 | psi-mi:“MI:0915”(physical association) | 0.370 |
| TPTE2 | EPHA2 | psi-mi:“MI:0915”(physical association) | 0.370 |
| P | psi-mi:“MI:0914”(association) | 0.350 | |
| TPTE2 | DNAJB5 | psi-mi:“MI:0914”(association) | 0.350 |
| TPTE2 | ARRB2 | psi-mi:“MI:0914”(association) | 0.350 |
BioGRID (112): HAUS1 (Affinity Capture-MS), OTUD4 (Affinity Capture-MS), PEX19 (Affinity Capture-MS), PPP2R3A (Proximity Label-MS), CCDC14 (Proximity Label-MS), CEP290 (Proximity Label-MS), NCKAP5L (Proximity Label-MS), AKAP9 (Proximity Label-MS), KIAA0753 (Proximity Label-MS), PIBF1 (Proximity Label-MS), CCDC77 (Proximity Label-MS), CCDC18 (Proximity Label-MS), CCDC61 (Proximity Label-MS), SSFA2 (Proximity Label-MS), CEP72 (Proximity Label-MS)
ESM2 similar proteins: A0A0G2JXT6, A0JMF6, A0JMK5, A2ALK8, A2BGG1, A6QLT4, A7MB43, G5ED68, O13819, O14830, P26045, P33402, P51432, Q09M05, Q13496, Q13613, Q15111, Q3USB7, Q4KWH5, Q4R6N0, Q4U2V3, Q52KU6, Q5EB32, Q5F452, Q5R6F6, Q5R9S3, Q5U581, Q62688, Q6AXQ4, Q6NU08, Q6TEL0, Q6XPS3, Q7TPM9, Q7ZXF1, Q8K394, Q8NCE2, Q8VE11, Q8VEL2, Q96EF0, Q96MI9
Diamond homologs: E9Q0S6, G5EE01, O08586, O54857, O94526, P56180, P60483, P60484, Q04205, Q4R6N0, Q54JL7, Q5B323, Q5SSZ5, Q68CZ2, Q6XPS3, Q86IL4, Q8H106, Q8T9S7, Q99KY4, Q9FLZ5, Q9GLM4, Q9HBL0, Q9LT75, Q9P7H1, Q9PUT6, A0AUV4, A8WYE4, B0WAU8, D2I3C6, D3ZBE5, F1LP90, F1MH24, F1SPM8, G5ECQ3, O13773, O14976, O34507, O43066, O75061, O75716
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
104 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 74 |
| Likely benign | 7 |
| Benign | 1 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
2875 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 13:19425018:C:CC | acceptor_gain | 1.0000 |
| 13:19450165:C:CC | acceptor_gain | 1.0000 |
| 13:19451163:A:AC | donor_gain | 1.0000 |
| 13:19451164:C:CT | donor_gain | 1.0000 |
| 13:19451164:CTG:C | donor_gain | 1.0000 |
| 13:19465317:AC:A | acceptor_gain | 1.0000 |
| 13:19465318:CC:C | acceptor_gain | 1.0000 |
| 13:19482558:C:CT | acceptor_gain | 1.0000 |
| 13:19425016:TT:T | acceptor_gain | 0.9900 |
| 13:19438150:CTTC:C | acceptor_gain | 0.9900 |
| 13:19438154:C:CC | acceptor_gain | 0.9900 |
| 13:19438154:CTA:C | acceptor_loss | 0.9900 |
| 13:19438155:T:C | acceptor_loss | 0.9900 |
| 13:19450161:CTCA:C | acceptor_gain | 0.9900 |
| 13:19450163:CA:C | acceptor_gain | 0.9900 |
| 13:19451160:CATA:C | donor_gain | 0.9900 |
| 13:19451222:CTTC:C | acceptor_gain | 0.9900 |
| 13:19464517:CGTT:C | acceptor_gain | 0.9900 |
| 13:19465250:CAAA:C | donor_loss | 0.9900 |
| 13:19465251:AAACC:A | donor_loss | 0.9900 |
| 13:19465252:AAC:A | donor_loss | 0.9900 |
| 13:19465253:A:G | donor_loss | 0.9900 |
| 13:19465254:C:CG | donor_loss | 0.9900 |
| 13:19465319:C:T | acceptor_gain | 0.9900 |
| 13:19473912:AC:A | donor_gain | 0.9900 |
| 13:19473913:CC:C | donor_gain | 0.9900 |
| 13:19473913:CCCTT:C | donor_gain | 0.9900 |
| 13:19482559:A:T | acceptor_gain | 0.9900 |
| 13:19492904:C:CC | acceptor_gain | 0.9900 |
| 13:19493443:CTTA:C | donor_loss | 0.9900 |
AlphaMissense
0 scored. Top likely-pathogenic:
dbSNP variants (sampled 300 via entrez): RS1000008667 (13:19468361 G>C), RS1000017231 (13:19558265 C>A,T), RS1000081267 (13:19424464 T>A,C), RS1000115151 (13:19538013 A>T), RS1000124539 (13:19519811 A>G), RS1000125070 (13:19504916 T>C), RS1000155530 (13:19519492 G>T), RS1000209057 (13:19523803 G>A), RS1000232115 (13:19524216 A>G), RS1000234488 (13:19467904 T>C,G), RS1000269193 (13:19511397 A>G), RS1000353241 (13:19497734 G>C,T), RS1000371772 (13:19430104 G>A), RS1000388654 (13:19526676 T>C), RS1000458000 (13:19517579 A>C)
Disease associations
OMIM: gene MIM:606791 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
1 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST010678_5 | Liver fibrosis (total hepatic collagen content) | 8.000000e-06 |
EFO canonical traits (1, from GWAS)
| EFO ID | Trait name |
|---|---|
| EFO:0010576 | liver fibrosis measurement |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
11 total (human), top 11 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| bisphenol A | increases methylation | 1 |
| nickel sulfate | increases expression | 1 |
| tanespimycin | increases expression | 1 |
| scriptaid | affects expression | 1 |
| Hydralazine | affects cotreatment, increases expression | 1 |
| Methotrexate | increases expression | 1 |
| Silicon Dioxide | decreases expression | 1 |
| Valproic Acid | affects cotreatment, increases expression | 1 |
| Aflatoxin B1 | decreases expression | 1 |
| Permethrin | decreases expression | 1 |
| Nanotubes, Carbon | increases expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.